J. Scott Wolchko, President and CEO at FATE THERAPEUTICS INC (FATE), sold 42,034 shares at $14.44 ($607K) on 2019-10-15, disclosed to the SEC on 2019-10-16.
Open-market sale of $607k FATE by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.44 | 21,017 | $303K | 50.0% |
| 2 | $14.44 | 21,017 | $303K | 50.0% |
| Total | $14.44 avg | 42,034 | $607K | 100% |
| Filing → |
| FATE | SELL | 2022-07-25 | $2.4M | — | Filing → |
| FATE | SELL | 2022-04-25 | $2.6M | — | Filing → |
| FATE | SELL | 2022-01-24 | $2.0M | — | Filing → |